Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.
Tagged patents · clear
Just recently, in the Life Spine, Inc. v. Aegis Spine, Inc., Case No. 21-1649 (7th Cir. Aug. 9, 2021) (St. Eve, J.), the Seventh Circuit noted that “a limited disclosure” does not destroy all trade secret protection on a product, allowing a…
Especially now with the COVID-19 vaccine patent waiver debate, it comes to our mind the relationship between patent system and access to medicine. As in all over fields where intellectual property protection exists, without appropriate patent protection…
Tomorrow, we are releasing our Third Annual Patent Prosecution Intelligence Report , where we have analyzed the patent prosecution data for five consecutive years (2016-2020), covering various statistics related to the USPTO, Technology Centers, Art Units,…
Earlier this year, we reviewed the sharp increase in patent litigation in 2020 ( Patexia Insight 96 ). District Court patent cases rose 17 percent in 2020 compared to 2019 (excluding ANDA cases). This trend seems to continue in 2021 as filing activity in…
Last couple of weeks, we looked at the impact of COVID-19 and recession on IP, specifically patent prosecution. We concluded that there would be at least two to four percent decline in the number of applications for the next couple of years ( Patexia…
In BASF Corp. v. SNF Holding Co, Appeal No. 2019-1243 (Fed. Cir., April 8 2020), a Fed. Cir. panel of Judges Lourie, Moore and Chen – Lourie writing—reviewed the district court’s holding that a BASF patent (U.S. Pat. No. 5,663,329) on a…
Coronavirus and its global impact have affected almost every sector of the economy. With all of the job losses and the continued lockdown in more than 80% of US cities, at this point, it is clear we are in one of the worst recessions in recent decades.…
This “Guide” is a 1528 page book published by the Chartered Institute of Patent Attorneys via Thomson Reuters, and edited by Paul Cole and Richard Davis. Of course, it mostly focused on UK patent law, but draws upon a variety of sources,…
Today, a divided Fed. Cir. panel reversed the district court’s decision invalidating the claim of two Illumina patents, U.S. Pat. Nos. 9,580,751 and 9,738,931, as directed to a natural phenomenon (Illumina, Inc. v. Ariosa Diagnostics, Inc., Appeal…
In Galderma Labs. v. Teva Pharm. USA, Inc. , Appeal Nos. 2019-2396 and 2020-1213 (Fed. Cir,. January 29, 2020), a Fed. Cir. panel of Judges Moore, O’Malley and Stoll reversed a district court finding that three Galderma patents (US Pat. Nos.…
On January 15, 2020, President Trump signed a lengthy “Economic and Trade Agreement Between the Government of the [US] and the Government of [P. R. of China].” Chapter 1 is entitled “Intellectual Property” that contains Sections on…
Happy New Year! This morning, we released our first ITC Intelligence Report , where we looked at more than 7,000 attorneys, 400 law firms and 1,600 companies, measured their performance and activity over the last six years. In 2020, we plan to expand our…
